p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor

por Levesque, Aime A., Pappalardo, Rebecca M., Puli, Pawan, Enzor, Laura A., Angeles, Clara
Publicado 2022